EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Report of three azole-resistant Aspergillus fumigatus cases with TR34/L98H mutation in hematological patients in Barcelona, Spain

Patricia Monzo-Gallo, Ana Alastruey-Izquierdo, Mariana Chumbita, Tommaso Francesco Aiello, Antonio Gallardo-Pizarro, Olivier Peyrony, Christian Teijon-Lumbreras, Laura Alcazar-Fuoli, Mateu Espasa, Alex Soriano, Francesc Marco, Carolina Garcia-Vidal

Infection · 2024-10 · 52 (5) · 1651-1656

DOI: 10.1007/s15010-024-02236-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Infection, online erschienen am 27.05.2024. Verfasst von Patricia Monzo-Gallo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Carrer de Villarroel 170, 08036, Barcelona, Spain. …. Hauptthemen laut MEDLINE: Drug Resistance, Fungal, Azoles, Aspergillus fumigatus, Antifungal Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, Universitat de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to report the emergence of azole-resistant invasive aspergillosis in hematologic patients admitted to a tertiary hospital in Spain during the last 4 months.

Methods

Prospective, descriptive study was performed to describe and follow all consecutive proven and probable invasive aspergillosis resistant to azoles from hematological cohort during the last 4 months. All patients had fungal cultures and antifungal susceptibility or real-time PCR detection for Aspergillus species and real-time PCR detection for azole-resistant mutation.

Results

Four cases of invasive aspergillosis were diagnosed in 4 months. Three of them had azole-resistant aspergillosis. Microbiological diagnosis was achieved in three cases by means of fungal culture isolation and subsequent antifungal susceptibility whereas one case was diagnosed by PCR-based aspergillus and azole resistance detection. All the azole-resistant aspergillosis presented TR34/L98H mutation. Patients with azole-resistant aspergillosis had different hematologic diseases: multiple myeloma, lymphoblastic acute leukemia, and angioimmunoblastic T lymphoma. Regarding risk factors, one had prolonged neutropenia, two had corticosteroids, and two had viral co-infection. Two of the patients developed aspergillosis under treatment with azoles.

Conclusion

We have observed a heightened risk of azole-resistant aspergillosis caused by A. fumigatus harboring the TR 34 /L98H mutation in patients with hematologic malignancies. The emergence of azole-resistant aspergillosis raises concerns for the community, highlighting the urgent need for increased surveillance and the importance of susceptibility testing and new drugs development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, FungalAzolesAspergillus fumigatusAntifungal AgentsMutationAspergillosisHumansSpainMaleFemaleMiddle AgedAgedProspective StudiesAdultMicrobial Sensitivity TestsHematologic Neoplasms

Stichwörter der Autor:innen

Aspergillus fumigatus sensu strictoAzole-resistant AspergillusHematologic patientsInvasive aspergillosisTR34/L98H mutation

Substanzen

AzolesAntifungal Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Carrer de Villarroel 170, 08036, Barcelona, Spain. pmonzom@clinic.cat.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain. pmonzom@clinic.cat.
  • ISCIII, Instituto de Salud Carlos III, Madrid, Spain.
  • CIBERINFECT, Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Carrer de Villarroel 170, 08036, Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036, Barcelona, Spain.

Förderung

  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Instituto de Salud Carlos III
  • Universitat de Barcelona

Zitieren

APA

Monzo-Gallo, P., Alastruey-Izquierdo, A., Chumbita, M., Aiello, T. F., Gallardo-Pizarro, A., Peyrony, O., Teijon-Lumbreras, C., Alcazar-Fuoli, L., Espasa, M., Soriano, A., Marco, F., & Garcia-Vidal, C. (2024). Report of three azole-resistant Aspergillus fumigatus cases with TR34/L98H mutation in hematological patients in Barcelona, Spain. Infection, 52(5), 1651-1656. https://doi.org/10.1007/s15010-024-02236-7

Vancouver

Monzo-Gallo P, Alastruey-Izquierdo A, Chumbita M, Aiello TF, Gallardo-Pizarro A, Peyrony O, et al. Report of three azole-resistant Aspergillus fumigatus cases with TR34/L98H mutation in hematological patients in Barcelona, Spain. Infection. 2024;52(5):1651-1656. doi:10.1007/s15010-024-02236-7

BibTeX
@article{MonzoGallo2024,
  author = {Monzo-Gallo, Patricia and Alastruey-Izquierdo, Ana and Chumbita, Mariana and Aiello, Tommaso Francesco and Gallardo-Pizarro, Antonio and Peyrony, Olivier and Teijon-Lumbreras, Christian and Alcazar-Fuoli, Laura and Espasa, Mateu and Soriano, Alex and Marco, Francesc and Garcia-Vidal, Carolina},
  title = {Report of three azole-resistant Aspergillus fumigatus cases with TR34/L98H mutation in hematological patients in Barcelona, Spain},
  journal = {Infection},
  year = {2024},
  volume = {52},
  number = {5},
  pages = {1651--1656},
  doi = {10.1007/s15010-024-02236-7}
}
Kostenlos starten →